×

Ackman to CNBC: Support Actavis-Allergan deal

10:27 AM ET Tue, 18 Nov 2014

CNBC's David Faber reports investor Bill Ackman has told CNBC he will withdraw from the special meeting on December 18th where Actavis shareholders could have voted on new directors.